Crossmark

Position statement on the use of albumin in liver cirrhosis

Crossref DOI link: https://doi.org/10.1016/j.aohep.2022.100708

Published Print: 2022-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Castro-Narro, Graciela

Moctezuma-Velázquez, Carlos

Male-Velázquez, Rene

Trejo-Estrada, Rafael

Bosques, Francisco Javier

Moreno-Alcántar, Rosalba

Rodríguez-Hernández, Heriberto

Bautista-Santos, Aleida

Córtez-Hernández, Carlos

Cerda-Reyes, Eira

Pérez-Escobar, Juanita

Aldana-Ledesma, Juan Manuel

Aguirre-Valadez, Jonathan

Ruiz-Velasco, José Antonio Velarde

Contreras-Omaña, Raúl

Miranda-Zazueta, Godolfino

Reyes-Bastidas, Monica del Rocío

Meza-Cardona, Javier Manuel

Chávez-Tapia, Norberto

Fernández-Pérez, Nicolas Joaquín

García-Jiménez, Edgar Santino

Torre, Aldo
License Information

Text and Data Mining valid from 2022-07-01

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-04-04
More Information

This article is maintained by: Elsevier

Article Title: Position statement on the use of albumin in liver cirrhosis

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2022.100708

Content Type: article

Copyright: © 2022 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.